Pharming (PHAR) Gross Profit Growth (1y) (2021 - 2026)
Pharming (PHAR) Gross Profit Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - | - |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 41.37% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 7.76% |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.14 Bn | 3.31 Bn | 16.94% |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | 68.41% |
| 9 | Revolution Medicines | 37.46 Bn | 37.46 Bn | - | - |
| 10 | Pharming | 8.96 Bn | 8.91 Bn | 65.80 Mn | 92,980,075.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 92,980,075.50% |
| Dec 31, 2025 | -52.90% |
| Sep 30, 2025 | 132,646,958.82% |
| Jun 30, 2025 | -100.00% |
| Mar 31, 2025 | 49.94% |
| Dec 31, 2024 | -100.00% |
| Sep 30, 2024 | -100.00% |
| Jun 30, 2024 | -100.00% |
| Mar 31, 2024 | -100.00% |
| Dec 31, 2023 | 104,509,563.56% |
| Sep 30, 2023 | 12.46% |
| Jun 30, 2023 | 106,724,411.93% |
| Mar 31, 2023 | -7.76% |
| Dec 31, 2022 | 66.71% |
| Sep 30, 2022 | 11.25% |
| Jun 30, 2022 | 2.33% |
| Mar 31, 2022 | 7.75% |
| Dec 31, 2021 | -3.57% |
| Sep 30, 2021 | -3.26% |